You are here

Article Text

Article menu
Download PDFPDF
Commentary
Osteoporosis: a survey of consultant ophthalmologists
  1. P HODGKINS
  1. Department of Ophthalmology, Queen Alexandra Hospital, Cosham, Portsmouth PO6 3LY
  2. Department of Rheumatology, Queen Alexandra Hospital, Cosham, Portsmouth PO6 3LY
  3. Department of Ophthalmology, Queen Alexandra Hospital, Cosham, Portsmouth PO6 3LY
  1. R G HULL
  1. Department of Ophthalmology, Queen Alexandra Hospital, Cosham, Portsmouth PO6 3LY
  2. Department of Rheumatology, Queen Alexandra Hospital, Cosham, Portsmouth PO6 3LY
  3. Department of Ophthalmology, Queen Alexandra Hospital, Cosham, Portsmouth PO6 3LY
  1. A R EVANS,
  2. M N JEFFREY
  1. Department of Ophthalmology, Queen Alexandra Hospital, Cosham, Portsmouth PO6 3LY
  2. Department of Rheumatology, Queen Alexandra Hospital, Cosham, Portsmouth PO6 3LY
  3. Department of Ophthalmology, Queen Alexandra Hospital, Cosham, Portsmouth PO6 3LY

    https://doi.org/10.1136/bjo.81.4.260

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

      A questionnaire designed to elicit corticosteroid prescribing habits and subsequent osteoporosis prophylaxis was sent to all consultant ophthalmologists in the United Kingdom. Replies were received from 467/560 (81%). Corticosteroids at doses greater than 5 mg per day were used for 3 months or more by 343/460 (75%) and no advice on osteoporosis prevention was given by 260 (75%) of this group.

      Currently there is a lack of clear recommendations on osteoporosis prophylaxis for patients on steroids. However, as bone densitometry is becoming more readily available, prophylaxis is becoming more popular. The Chief Medical Officer’s Advisory Group on osteoporosis reported1 that patients taking oral steroids equivalent to 5 mg prednisolone or more daily for longer than 3 months are at risk of osteoporosis and should undergo bone densitometry. …

      View Full Text